GLOBAL health-oriented and wellness direct selling company DXN Holdings Bhd has been relisted on Bursa Malaysia’s main market on May 19, 2023 – on the heels of its recent announcement of ...

DXN manufactures and markets dietary supplements containing the mushrooms Ganoderma or Lingzhi. Its products are marketed by affiliated companies Daehsan, Ltd and Daxen in some countries in Europe.

DXN’s products are based on active natural ingredients such as Ganoderma, Spirulina and Cordyceps. The company covers food and beverages, cosmetics, health supplements and other market segments.

With over 16.4 million registered distributors worldwide, DXN is solidifying its position as one of the world leader in Ganoderma products.

Under Lim’s leadership, DXN has unveiled numerous potential benefits of Ganoderma Lucidum and its impact on human health. He firmly believes that this partnership will foster greater ...

DXN Holdings Bhd's estimated fair value is RM0.65 based on 2 Stage Free Cash Flow to Equity Current share price of RM0.68 suggests DXN Holdings Bhd is potentially trading close to its fair value ...